Increased expression of unmethylated CDKN2D by 5-aza-2′-deoxycytidine in human lung cancer cells

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Oncogene

• Publication date

  2001-11-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1204970PMID 11753657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylation matters

  2001cited by this paper
• Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

  2001influential reference
• DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors.

  2001cited by this paper
• Mammalian methyltransferases and methyl-CpG-binding domains: proteins involved in DNA methylation.

  2000cited by this paper
• Promoter-region hypermethylation and gene silencing in human cancer.

  2000cited by this paper
• DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci

  2000cited by this paper
• CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus

  2000cited by this paper
• Aberrant CpG-island methylation has non-random and tumour-type–specific patterns

  2000cited by this paper
• Epigenetic gene silencing in cancer.

  2000cited by this paper
• DNA methylation: past, present and future directions.

  2000cited by this paper
• Relationship between transcription and DNA methylation.

  2000cited by this paper
• DNA methyltransferase Dnmt1 associates with histone deacetylase activity

  2000cited by this paper
• DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters

  2000cited by this paper
• Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene

  2000cited by this paper
• Promoter2.0: for the recognition of PolII promoter sequences

  1999influential reference
• Cancer-epigenetics comes of age

  1999cited by this paper
• DNA methylation and chromatin modification.

  1999cited by this paper
• Stochastic segment models of eukaryotic promoter regions.

  1999cited by this paper
• Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.

  1999cited by this paper
• Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

  1999cited by this paper
• The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.

  1999cited by this paper
• Alterations in DNA methylation: a fundamental aspect of neoplasia.

  1998cited by this paper
• DNA methylation models histone acetylation

  1998cited by this paper
• Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

  1998cited by this paper
• Repeat-induced gene silencing in mammals

  1998cited by this paper
• Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression

  1997cited by this paper
• Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions inde Novo Methylation*

  1997cited by this paper
• A 5' differentially methylated sequence and the 3'-flanking region are necessary for H19 transgene imprinting

  1997cited by this paper
• Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.

  1996cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.

  1996cited by this paper
• Predicting Pol II promoter sequences using transcription factor binding sites.

  1995influential reference
• Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.

  1995cited by this paper
• Purification of CpG islands using a methylated DNA binding column

  1994cited by this paper
• Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.

  1994cited by this paper
• Increased cytosine DNA-methyltransferase activity during colon cancer progression.

  1993cited by this paper
• Role for DNA methylation in genomic imprinting

  1993cited by this paper
• Effects of DNA methylation on DNA-binding proteins and gene expression.

  1993cited by this paper
• Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.

  1992cited by this paper
• In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1.

  1990cited by this paper
• A CACGTG motif of the Antirrhinum majus chalcone synthase promoter is recognized by an evolutionarily conserved nuclear protein.

  1989cited by this paper
• Two regulatory domains flank the mouse H19 gene

  1988cited by this paper
• CpG islands in vertebrate genomes.

  1987influential reference

• Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities

  2022cites this paper
• Effect of 5'-fluoro-2'-deoxycytidine, 5-azacytidine, and 5-aza-2'–deoxycytidine on DNA Methyltransferase 1, CIP/KIP Family, and INK4a/ARF in Colon Cancer HCT-116 Cell Line

  2022cites this paper
• LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis

  2021cites this paper
• Editorial: Genetic and Epigenetic Control of Immune Responses

  2021cites this paper
• Effect of 5- Azacytidine on the Cell Growth Inhibition and Apoptosis Induction Lung Cancer A549 Cell Line

  2020cites this paper
• The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy

  2020cites this paper
• Gestational oral low-dose estradiol-17β induces altered DNA methylation of CDKN2D and PSAT1 in embryos and adult offspring

  2018cites this paper
• Effects of 5-Aza-2′-deoxycytidine (decitabine) on gene expression

  2018cites this paper
• Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation

  2017cites this paper
• 5-azacytidine affects TET2 and histone transcription and reshapes morphology of human skin fibroblasts

  2016cites this paper
• Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis

  2016cites this paper
• Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB

  2016cites this paper
• Epigenetics of gastric cancer.

  2015cites this paper
• Dynamic Changes of Sp6 Transgene Expression in Dental Epithelial Cells during Long-term Culture

  2015cites this paper
• Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line.

  2015cites this paper
• A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia

  2015cites this paper
• Loss of expression of cyclin d2 by aberrant DNA methylation: a potential biomarker in vietnamese breast cancer patients.

  2015cites this paper
• Regulation of MT1-MMP/MMP-2/TIMP-2 axis in human placenta

  2015cites this paper
• DNA methyltransferase 3A promotes cell proliferation by silencing CDK inhibitor p18INK4C in gastric carcinogenesis

  2015cites this paper
• Investigation of the pituitary epigenome : a genome-wide analysis of changes associated with sporadic tumours

  2014cites this paper
• High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines

  2014cites this paper
• Abstract A19: Epigenetic drug combination induces genome-wide demethylation and altered gene expression in neuro-ectodermal tumor-derived cell lines

  2014cites this paper
• The induction of KLF4 expression by coupled epigenetic therapies: potential association with the WNT signalling pathway in colorectal cancer cells

  2014cites this paper
• Inhibition of bladder cancer invasion by Sp1‐mediated BTG2 expression via inhibition of DNA methyltransferase 1

  2014cites this paper
• Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancer

  2014cites this paper
• p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.

  2014cites this paper
• Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy

  2013cites this paper
• DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells

  2013cites this paper
• Intragenic epigenetic changes modulate NCAM alternative splicing in neuronal differentiation

  2013cites this paper
• Epigenetic drug combination induces genome-wide demethylation and altered gene expression in neuro-ectodermal tumor-derived cell lines

  2013cites this paper
• Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.

  2012cites this paper
• The pituitary tumour epigenome: aberrations and prospects for targeted therapy

  2012cites this paper
• 5‐Aza‐2'‐deoxycytidine reactivates gene expression via degradation of pRb pocket proteins

  2012cites this paper
• Current limitations and future opportunities for epigenetic therapies.

  2012cites this paper
• DNA Methylation and Histone Deacetylation: Interplay and Combined Therapy in Cancer

  2012cites this paper
• Interplay between DNA methylation and chromatin structure during the epigenetic resilencing of tumor suppressor genes

  2011cites this paper
• Secreted frizzled‐related protein‐5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer

  2011cites this paper
• Chromatin-Modifying Agents Increase Transcription of CYP46A1, a Key Player in Brain Cholesterol Elimination

  2011cites this paper
• THE CONSUMPTION OF REGIONAL FRUITS IN WESTERN BRAZILIAN AMAZON

  2011cites this paper
• Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma.

  2011cites this paper
• Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines.

  2011cites this paper
• DNA methyltransferase inhibition may limit cancer cell growth by disrupting ribosome biogenesis

  2011cites this paper
• 5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis.

  2010influential citation
• Universidade de Lisboa

  2010cites this paper
• Resistance to 5-aza-2'-deoxycytidine in genic regions compared to non-genic repetitive sequences.

  2010cites this paper
• Molecular Cancer apeutics linical Development binations of DNA Methyltransferase and Histone cetylase Inhibitors Induce DNA Damage in Small l Lung Cancer Cells : Correlation of Resistance with Ther-Stimulated Gene Expression

  2010cites this paper
• An epigenetic mechanism for capecitabine resistance in mesothelioma.

  2010cites this paper
• Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression

  2010cites this paper
• Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies

  2010cites this paper
• Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1

  2010cites this paper
• DNA Methyltransferase 1-associated Protein (DMAP1) Is a Co-repressor That Stimulates DNA Methylation Globally and Locally at Sites of Double Strand Break Repair*

  2010cites this paper
• Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report.

  2010cites this paper
• Changes in chromatin structure and methylation of the human interleukin‐1β gene during monopoiesis

  2010cites this paper
• Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A.

  2010cites this paper
• Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)

  2009cites this paper
• Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.

  2009cites this paper
• Growth inhibition of human cancer cells by 5-aza-2′-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status

  2009cites this paper
• Radiosensitizing potential of epigenetic anticancer drugs.

  2009cites this paper
• Advancesinpreclinicalsmall moleculesforthetreatment ofNSCLC

  2009cites this paper
• Epigenetic reversal of acquired resistance to 5-fluorouracil treatment

  2009cites this paper
• Epigenetics and cancer treatment.

  2009cites this paper
• Advances in preclinical small molecules for the treatment of NSCLC

  2009cites this paper
• Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.

  2009cites this paper
• SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response

  2008cites this paper
• DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines

  2008cites this paper
• HDAC Inhibitors Act with 5-aza-2′-Deoxycytidine to Inhibit Cell Proliferation by Suppressing Removal of Incorporated Abases in Lung Cancer Cells

  2008cites this paper
• Histone Deacetylase Inhibitor Depsipeptide Activates Silenced Genes through Decreasing both CpG and H3K9 Methylation on the Promoter

  2008influential citation
• Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma.

  2008cites this paper
• Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.

  2008cites this paper
• The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer.

  2008cites this paper
• Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics

  2008cites this paper
• BIOLOGY AND EPIDEMIOLOGY OF LUNG CANCER

  2008cites this paper
• p21WAF1/CIP1 induction by 5-azacytosine nucleosides requires DNA damage

  2008cites this paper
• 5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation

  2007cites this paper
• Analysis of prognostic and drug resistance markers in lung cancer

  2007cites this paper
• Retinoic acid receptor β2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells

  2007cites this paper
• Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: Identification of apoptotic genes as targets for demethylation

  2007cites this paper
• clinical implications Lung cancer • 9: Molecular biology of lung cancer:

  2007cites this paper
• Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.

  2007cites this paper
• 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.

  2006cites this paper
• Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report.

  2006cites this paper
• Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines.

  2006cites this paper
• Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition

  2006cites this paper
• 5-Aza-2'-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer).

  2006cites this paper
• CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo

  2006cites this paper
• Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.

  2005cites this paper
• Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review

  2005cites this paper
• Induction of gene expression by 5-Aza-2′-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms

  2005cites this paper
• Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs.

  2005cites this paper
• DNA methylation and cancer therapy: new developments and expectations

  2005cites this paper
• Aberrant promoter methylation of p16INK4a, RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer

  2005cites this paper
• Clinical Pharmacology of MS-275, A Histone Deacetylase Inhibitor

  2005cites this paper
• Mechanisms of DNA Demethylating Drugs Against Cancer Progression

  2005cites this paper
• ABERRANT EPIGENETICS IN THE MOLECULAR PATHOGENESIS OF HUMAN ACUTE MYELOID LEUKEMIA

  2005cites this paper
• Immortalization of human small airway epithelial cells by ectopic expression of telomerase.

  2005cites this paper
• Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia

  2005cites this paper
• DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results.

  2005cites this paper
• Coordinated Changes in DNA Methylation and Histone Modifications Regulate Silencing/Derepression of Luteinizing Hormone Receptor Gene Transcription

  2005cites this paper
• The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.

  2005cites this paper
• Targeting the epigenome for the treatment and prevention of lung cancer.

  2005cites this paper